Editorial: Risk Factors for Alzheimer's Disease

Ines Moreno-Gonzalez^{1

2

3

4}, Rodrigo Morales^{3

4}, David Baglietto-Vargas^{1

2}, Raquel Sanchez-Varo^{1

2}

Affiliations

¹ Departamento Biologia Celular, Genetica y Fisiologia, Facultad de Ciencias, Instituto de Investigacion Biomedica de Malaga-IBIMA, Universidad de Malaga, Málaga, Spain.
² Networking Research Center on Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
³ Department of Neurology, The University of Texas Health Science Center at Houston, Houston, TX, United States.
⁴ Centro Integrativo de Biología y Química Aplicada (CIBQA), Universidad Bernardo O'Higgins, Santiago, Chile.

Editorial

Ines Moreno-Gonzalez et al. Front Aging Neurosci. 2020.

. 2020 May 7:12:124.

doi: 10.3389/fnagi.2020.00124. eCollection 2020.

Ines Moreno-Gonzalez^{1

2

3

4}, Rodrigo Morales^{3

4}, David Baglietto-Vargas^{1

2}, Raquel Sanchez-Varo^{1

2}

¹ Departamento Biologia Celular, Genetica y Fisiologia, Facultad de Ciencias, Instituto de Investigacion Biomedica de Malaga-IBIMA, Universidad de Malaga, Málaga, Spain.
² Networking Research Center on Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
³ Department of Neurology, The University of Texas Health Science Center at Houston, Houston, TX, United States.
⁴ Centro Integrativo de Biología y Química Aplicada (CIBQA), Universidad Bernardo O'Higgins, Santiago, Chile.

No abstract available

Keywords: Alzheimer's disease; genetic variance; modifiable; peripheral; risk factors.

Comment on

1. Ghiso J., Calero M., Matsubara E., Governale S., Chuba J., Beavis R., et al. . (1997). Alzheimer's soluble amyloid beta is a normal component of human urine. FEBS Lett. 408, 105–108. 10.1016/s0014-5793(97)00400-6 - DOI - PubMed
1. Hone E., Martins I. J., Fonte J., Martins R. N. (2003). Apolipoprotein E influences amyloid-beta clearance from the murine periphery. J. Alzheimer's Dis 5, 1–8. 10.3233/JAD-2003-5101 - DOI - PubMed
1. Moir R. D., Lathe R., Tanzi R. E. (2018). The antimicrobial protection hypothesis of Alzheimer's disease. Alzheimers Dement. 14, 1602–1614. 10.1016/j.jalz.2018.06.3040 - DOI - PubMed
1. Soscia S. J., Kirby J. E., Washicosky K. J., Tucker S. M., Ingelsson M., Hyman B., et al. . (2010). The Alzheimer's disease-associated amyloid β-protein is an antimicrobial peptide. PLoS ONE 5:e9505. 10.1371/journal.pone.0009505 - DOI - PMC - PubMed